Methylenedioxyallylamphetamine (MDAL or 3,4-methylenedioxy-N-allylamphetamine) is a lesser-known drug. MDAL entry It is the N-allyl derivative of 3,4-methylenedioxyamphetamine (MDA).
Use and effects In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists MDAL's minimum dose as 180 mg orally and its duration as unknown. MDAL produces few to no effects on its own, but may enhance the effects of psychedelic drugs like LSD.
Chemistry Synthesis The chemical synthesis of MDAL has been described.
Society and culture Legal status United Kingdom This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.
See also Substituted methylenedioxyphenethylamine Phenylpropylaminopentane MDPR
References
External links MDAL - Isomer Design MDAL - PiHKAL - Erowid MDAL - PiHKAL - Isomer Design